UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043421
Receipt number R000049347
Scientific Title Evaluation of the Event-Related Psychological Distress Rating Scale (ERPD-24) in patients with mood disorders
Date of disclosure of the study information 2021/02/23
Last modified on 2024/04/13 10:28:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Event-Related Psychological Distress Rating Scale (ERPD-24) in patients with mood disorders

Acronym

Evaluation of the Event-Related Psychological Distress Rating Scale (ERPD-24) in patients with mood disorders

Scientific Title

Evaluation of the Event-Related Psychological Distress Rating Scale (ERPD-24) in patients with mood disorders

Scientific Title:Acronym

Evaluation of the Event-Related Psychological Distress Rating Scale (ERPD-24) in patients with mood disorders

Region

Japan


Condition

Condition

Mood disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the severity of ERPD by using the ERPD-24 in patients with major depression and bipolar disorder comparing to healthy people.

Basic objectives2

Others

Basic objectives -Others

To explore the relationships between ERPD and other clinical features assessed in this study to clarify the pathophysiology of ERPD in those.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Examination of the score and content of a new rating scale (ERPD-24) for bipolar disorder, depression, normal subjects, and different mood states

Key secondary outcomes

Relationship between scores on the new rating scale (ERPD-24) and the Quick Inventory of Depressive Symptomatology, the Young Mania Rating Scale, the State-Trait Anxiety Inventory, the Liebowitz Social Anxiety Scale, the Autism-Spectrum Quotient, the ADA(anxious-depressive attack), and the Impact of Event Scale-Revised


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1 Patients who are diagnosed with depression and bipolar disorder according to DSM-5 criteria and healthy people
2 Patients who have ERPD
3 Patients who are commuting to or hospitalized in Chiba university hospital or cooperating medical institutions

Key exclusion criteria

1 Patients with schizophrenia, major depression disorder, comorbid dementia, organic mental disorder, mental retardation
2 Patients who have trauma
3 significant risk of suicide
4 Patients whom examination doctor judge improper as a trial subject

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Masaomi
Middle name
Last name Iyo

Organization

Graduate school of medicine and school of medicine, Chiba university

Division name

Department of psychiatry

Zip code

260-8677

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, JAPAN

TEL

043-222-7171

Email

iyom@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Aiko
Middle name
Last name Sato

Organization

Graduate school of medicine and school of medicine, Chiba university

Division name

Department of psychiatry

Zip code

260-8677

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, JAPAN

TEL

043-222-7171

Homepage URL


Email

aikosato@chiba-u.jp


Sponsor or person

Institute

Chiba university hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kokoronokaze Clinic Funabashi
Chiba Prefecture Psychiatric Medical Center
Sodegaura Satsukidai Hospital
Douwakai Chiba Hospital
Fujita Hospital
International University of Health and Welfare Narita Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate school of medicine and school of medicine, Chiba university

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, JAPAN

Tel

043-222-7171

Email

None


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 01 Month 09 Day

Date of IRB

2021 Year 02 Month 22 Day

Anticipated trial start date

2021 Year 02 Month 23 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design:cross-sectional study
Way to recruit:We recruit patients who meet inclusion criteria and who are commuting to or hospitalized in Chiba university hospital or cooperating medical institutions from February 2021 to September 2023.
Scales:
1 The Mini-International Neuropsychiatric Interview (M.I.N.I.)
2 Quick Inventory of Depressive Symptomatology (QIDS-J)
3 The Young Mania Rating Scale (YMRS) ,bipolarity
4 State-Trait Anxiety Inventory (STAI)
5 Liebowitz Social Anxiety Scale (LSAS-J)
6 Autism-Spectrum Quotient (AQ)
7 Japanese Adult Reading Test 25(JART25)
8 Event-Related Psychological Distress rating scale 24 (ERPD-24)
9 Impact of Event Scale-Revised (IES-R)
10 about anxious-depressive attack (ADA)
11 Clinical Global Impression of Change (CGI-C)


Management information

Registered date

2021 Year 02 Month 23 Day

Last modified on

2024 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049347


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name